Savvy Updates, 1/6/25: Metformin, Islet Organoids, EssilorLuxottica & Pulse Audition Hearing Aid Eyeglasses, FDA OKs Generic GLP-1, January 2025 & Birthday & Diaversary
What is metformin’s secret sauce? New study shows how ‘wonder drug’ works in living animals from Northwestern University, published by MedicalXpress.com, 18 December 2024. A new Northwestern Medicine study has provided direct evidence in mice that...
Savvy Updates, 12/30/24: Abbott/Dexcom Reach CGM Agreement, Endocrinologist 5th Lowest on Physician Pay Scale, Happy New Year 2025!
Abbott, Dexcom settle global CGM patent litigation by Sean Whooley for DrugDeliveryBsuiness.com, 23 December 2024. Abbott announced that it reached an agreement with Dexcom to settle all outstanding patent disputes between companies. The patent litigation relates...
Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG was announced by AccessWire.com, 19 December 2024. Modular Medical, Inc., an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs...
Savvy Updates, 12/16/24: ADA DiabetesStandards of Care 2025, Cleerly CCTA, Eversense 365 Day CGM Video, Insulin Resistance & Aortic Stenosis, Medtronic CGM Data on Displays, Effort to Force Insurers, PBMs to Sell Pharmacy Businesses, Medicare Open Enrollment Stress
In this week’s issue of The Savvy Diabetic: ADA DiabetesStandards of Care 2025 Cleerly Coronary Computed Tomography Angiography (CCTA) Video: Implantable 365-Day CGM Procedure Biomarkers of Insulin Resistance & Aortic Stenosis Medtronic CGM Data on...
Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes
Insulet awarded $452M in EOFlow patent fight by Elise Reuter for MedTechDive.com, 5 December 2024. Insulet sued EOFlow and three former executives who joined the South Korea-based patch-pump maker, claiming the company “launched a plan to brazenly copy Insulet’s...
Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care
Embecta discontinues insulin patch pump development by Elise Reuter for MedTechDive.com, 26 November 2024. Embecta said it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The...
Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation
In this week’s issue of The Savvy Diabetic: FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Savvy Updates 11/18/24: NovoNordisk Phasing Out Human Insulin Pens, Sequel/Twiist AID, History of Artificial Pancreas
Novo Nordisk says it is gradually phasing out human insulin pens globally by Maggie Fick for Reuters.com, 14 November 2024. Novo Nordisk is gradually ending production of human insulin pens, as it spends billions to ramp up manufacturing of its popular obesity and...
Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design
Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the...
More Diabetes Blogs